InvestorsHub Logo
Followers 4
Posts 726
Boards Moderated 0
Alias Born 01/13/2014

Re: None

Friday, 11/13/2015 3:03:31 PM

Friday, November 13, 2015 3:03:31 PM

Post# of 115081
Meanwhile, someone - shade I believe - posited several weeks ago that acculife should somehow be compared to Fitbit, at least partly from a valuation disparity perspective. Fitbit shares were trading mid to high $30's at the time, and I said I was short from about $40. A secondary was priced last night at $29. 3mm shares were sold instead of intended 7mm. Stock is down another 6% or so in the low $27 range. Lesson... Whenever a so called investment banker or other paid optimist tries to sell you a story based on a discount valuation to an overpriced stock in an alleged peer group, run away.
This was post 24448 before the truth hater(s) hit